Related references
Note: Only part of the references are listed.The histone methyltransferase Setd8 acts in concert with c-Myc and is required to maintain skin
Iwona Driskell et al.
EMBO JOURNAL (2012)
Vitamin D and Cancer: Uncertainty Persists; Research Continues
Joanne Nicholas
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2011)
AlleleSeq: analysis of allele-specific expression and binding in a network framework
Joel Rozowsky et al.
MOLECULAR SYSTEMS BIOLOGY (2011)
Vitamin D and Prevention of Cancer - Ready for Prime Time?
JoAnn E. Manson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Vitamin D Receptor Deficiency Enhances Wnt/β-Catenin Signaling and Tumor Burden in Colon Cancer
Maria Jesus Larriba et al.
PLOS ONE (2011)
The molecular biology of head and neck cancer
C. Rene Leemans et al.
NATURE REVIEWS CANCER (2011)
Cross-regulation of signaling pathways: An example of nuclear hormone receptors and the canonical Wnt pathway
Marcy E. Beildeck et al.
EXPERIMENTAL CELL RESEARCH (2010)
A ChIP-seq defined genome-wide map of vitamin D receptor binding: Associations with disease and evolution
Sreeram V. Ramagopalan et al.
GENOME RESEARCH (2010)
The Down-regulation of the Human MYC Gene by the Nuclear Hormone 1α,25-dihydroxyvitamin D3 is Associated with Cycling of Corepressors and Histone Deacetylases
Sari Toropainen et al.
JOURNAL OF MOLECULAR BIOLOGY (2010)
Stimulation of Sirt1-Regulated FoxO Protein Function by the Ligand-Bound Vitamin D Receptor
Beum-Soo An et al.
MOLECULAR AND CELLULAR BIOLOGY (2010)
Hypovitaminosis D in developing countries-prevalence, risk factors and outcomes
Asma Arabi et al.
NATURE REVIEWS ENDOCRINOLOGY (2010)
The ubiquitous nature of cancer: the role of the SCFFbw7 complex in development and transformation
K. M. Crusio et al.
ONCOGENE (2010)
Unveiling Hair Follicle Stem Cells
Leilei Yang et al.
STEM CELL REVIEWS AND REPORTS (2010)
Suppression of β-catenin signaling by liver X receptor ligands
Shigeyuki Uno et al.
BIOCHEMICAL PHARMACOLOGY (2009)
1α,25-Dihydroxyvitamin D3 Reduces c-Myc Expression, Inhibiting Proliferation and Causing G1 Accumulation in C4-2 Prostate Cancer Cells
JoyAnn N. Phillips Rohan et al.
ENDOCRINOLOGY (2009)
HuR recruits let-7/RISC to repress c-Myc expression
Hyeon Ho Kim et al.
GENES & DEVELOPMENT (2009)
c-Myc activates multiple metabolic networks to generate substrates for cell-cycle entry
F. Morrish et al.
ONCOGENE (2009)
Biological determinants of endocrine resistance in breast cancer
Elizabeth A. Musgrove et al.
NATURE REVIEWS CANCER (2009)
Vitamin D and Human Health: Lessons from Vitamin D Receptor Null Mice
Roger Bouillon et al.
ENDOCRINE REVIEWS (2008)
Vitamin D signaling, infectious diseases, and regulation of innate immunity
John H. White
INFECTION AND IMMUNITY (2008)
Many forks in the path: cycling with FoxO
K. K. Ho et al.
ONCOGENE (2008)
FOXOs, cancer and regulation of apoptosis
Z. Fu et al.
ONCOGENE (2008)
FBW7 ubiquitin ligase: a tumour suppressor at the crossroads of cell division, growth and differentiation
Markus Welcker et al.
NATURE REVIEWS CANCER (2008)
To the moon and beyond - Humans are returning to the moon. This time the plan is to stay a while
Charles Dingell et al.
SCIENTIFIC AMERICAN (2007)
Transcriptional regulation of Bim by FoxO3A mediates hepatocyte lipoapoptosis
Fernando J. Barreyro et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Vitamin D deficiency
Michael F. Holick
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Extra-renal 25-hydroxyvitamin D3-1α-hydroxylase in human health and disease
Martin Hewison et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2007)
Vitamin D signalling pathways in cancer: potential for anticancer therapeutics
Kristin K. Deeb et al.
NATURE REVIEWS CANCER (2007)
Colorectal cancer and genetic alterations in the Wnt pathway
S. Segditsas et al.
ONCOGENE (2006)
Estrogen receptor target gene: An evolving concept
Jason S. Carroll et al.
MOLECULAR ENDOCRINOLOGY (2006)
Prospective study of predictors of vitamin D status and cancer incidence and mortality in men
E Giovannucci et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)
Polymorphisms of vitamin D receptor gene protect against the risk of head and neck cancer
ZS Liu et al.
PHARMACOGENETICS AND GENOMICS (2005)
Skp2 inhibits FOX01 in tumor suppression through ubiquitin-mediated degradation
H Huang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Myc-induced proliferation and transformation require Akt-mediated phosphorylation of FoxO proteins
C Bouchard et al.
EMBO JOURNAL (2004)
FoxOs at the crossroads of cellular metabolism, differentiation, and transformation
D Accili et al.
CELL (2004)
The F-Box protein Skp2 participates in c-Myc protelosornal degradation and acts as a cofactor for c-Myc-regulated transcription
N von der Lehr et al.
MOLECULAR CELL (2003)
Skp2 regulates Myc protein stability and activity
SY Kim et al.
MOLECULAR CELL (2003)
Inhibition of F-box protein p45SKP2 expression and stabilization of cyclin-dependent kinase inhibitor p27KIP1 in vitamin D analog-treated cancer cells
R Lin et al.
ENDOCRINOLOGY (2003)
Modulation of growth factor/cytokine synthesis and signaling by 1α,25-dihydroxyvitamin D3:: Implications in cell growth and differentiation
A Gurlek et al.
ENDOCRINE REVIEWS (2002)
Expression profiling in squamous carcinoma cells reveals pleiotropic effects of vitamin D3 analog EB1089 signaling on cell proliferation, differentiation, and immune system regulation
R Lin et al.
MOLECULAR ENDOCRINOLOGY (2002)
Regulation of gene expression by 1α,25-dihydroxyvitamin D3 and its analog EB1089 under growth-inhibitory conditions in squamous carcinoma cells
N Akutsu et al.
MOLECULAR ENDOCRINOLOGY (2001)
Deregulated expression of c-Myc depletes epidermal stem cells
RL Waikel et al.
NATURE GENETICS (2001)
c-Myc activation in transgenic mouse epidermis results in mobilization of stem cells and differentiation of their progeny
I Arnold et al.
CURRENT BIOLOGY (2001)
Extrarenal expression of 25-hydroxyvitamin D3-1α-hydroxylase
D Zehnder et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2001)
Share Paper
